Revive Therapeutics (RVV.C) and a psilocybin trial-test progress update
Revive Therapeutics (RVV.C) provided an update on their psilocybin development programs today. “Revive is building a specialty psilocybin-based product pipeline to treat mental illness, substance… Read More »Revive Therapeutics (RVV.C) and a psilocybin trial-test progress update




